Decreased risk of breast cancer associated with oral bisphosphonate therapy

References

• SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• CuzickJForbesJEdwardsRIBIS investigatorsFirst results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trialLancet2002360933681782412243915
   PubMed Web of Science ®Google Scholar
• FisherBCostantinoJPWickerhamDLTamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ Natl Cancer Inst19989018137113889747868
   PubMed Web of Science ®Google Scholar
• PowlesTJAshleySTidyASmithIEDowsettMTwenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trialJ Natl Cancer Inst200799428329017312305
   PubMedGoogle Scholar
• CummingsSREckertSKruegerKAThe effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationJAMA1999281232189219710376571
   PubMed Web of Science ®Google Scholar
• VogelVGCostantinoJPWickerhamDLNational Surgical Adjuvant Breast and Bowel ProjectUpdate of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancerCancer Prev Res (Phila)20103669670620404000
   PubMed Web of Science ®Google Scholar
• VogelVGCostantinoJPWickerhamDLNational Surgical Adjuvant Breast and Bowel Project (NSABP)Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialJAMA2006295232727274116754727
   PubMed Web of Science ®Google Scholar
• DavidsonNEKenslerTW“MAPping” the course of chemoprevention in breast cancerN Engl J Med2011364252463246421639807
   PubMed Web of Science ®Google Scholar
• GossPEIngleJNAles-MartinezJENCIC CTG MAP.3 Study InvestigatorsExemestane for breast-cancer prevention in post-menopausal womenN Engl J Med2011364252381239121639806
   PubMed Web of Science ®Google Scholar
• CuzickJAromatase inhibitors in prevention–data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study)Recent Results Cancer Res20031639610312903846
   PubMedGoogle Scholar
• TabaneKVorobiofDABone targeted therapies in early breast cancerCurr Treat Options Oncol201112441242321887503
   PubMed Web of Science ®Google Scholar
• RussellRGRogersMJBisphosphonates: from the laboratory to the clinic and back againBone19992519710610423031
   PubMed Web of Science ®Google Scholar
• van der PluijmGVloedgravenHvan BeekEvan der Wee-PalsLLöwikCPapapoulosSBisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitroJ Clin Invest19969836987058698861
   PubMed Web of Science ®Google Scholar
• FournierPBoissierSFilleurSBisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated ratsCancer Res200262226538654412438248
   PubMed Web of Science ®Google Scholar
• WoodJBonjeanKRuetzSNovel antiangiogenic effects of the bisphosphonate compound zoledronic acidJ Pharmacol Exp Ther200230231055106112183663
   PubMed Web of Science ®Google Scholar
• BoissierSFerrerasMPeyruchaudOBisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastasesCancer Res200060112949295410850442
   PubMed Web of Science ®Google Scholar
• BoissierSMagnettoSFrappartLBisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matricesCancer Res19975718389038949307266
   PubMed Web of Science ®Google Scholar
• ShipmanCMRogersMJApperleyJFRussellRGCroucherPIBisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activityBr J Haematol19979836656729332325
   PubMed Web of Science ®Google Scholar
• DielIJSolomayerEFCostaSDReduction in new metastases in breast cancer with adjuvant clodronate treatmentN Engl J Med199833963573639691101
   PubMed Web of Science ®Google Scholar
• ColemanREMarshallHCameronDBreast-cancer adjuvant therapy with zoledronic acidN Engl J Med2011365151396140521995387
   PubMed Web of Science ®Google Scholar
• GnantMMlineritschBSchippingerWABCSG-12 Trial InvestigatorsEndocrine therapy plus zoledronic acid in premenopausal breast cancerN Engl J Med2009360767969119213681
   PubMed Web of Science ®Google Scholar
• BrufskyAMHarkerWGBeckJTFinal 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozoleCancer201211851192120121987386
   PubMed Web of Science ®Google Scholar
• HortobagyiGNTheriaultRLLiptonALong-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study GroupJ Clin Oncol1998166203820449626201
   PubMed Web of Science ®Google Scholar
• EidtmannHde BoerRBundredNEfficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST StudyAnn Oncol2010112188219420444845
   PubMed Web of Science ®Google Scholar
• SaartoTBlomqvistCVirkkunenPElomaaIAdjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trialJ Clin Oncol2001191101711134190
   PubMed Web of Science ®Google Scholar
• NewcombPATrentham-DietzAHamptonJMBisphosphonates for osteoporosis treatment are associated with reduced breast cancer riskBr J Cancer2010102579980220160722
   PubMed Web of Science ®Google Scholar
• RennertGPinchevMRennertHSUse of bisphosphonates and risk of postmenopausal breast cancerJ Clin Oncol201028223577358120567021
   PubMed Web of Science ®Google Scholar
• CauleyJALucasFLKullerLHVogtMTBrownerWSCummingsSRBone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research GroupJAMA199627617140414088892715
   PubMed Web of Science ®Google Scholar
• ChenZArendellLAickinMCauleyJLewisCEChlebowskiRHip bone density predicts breast cancer risk independently of Gail score: results from the Women’s Health InitiativeCancer2008113590791518666209
   PubMed Web of Science ®Google Scholar
• BuistDSLaCroixAZBarlowWEWhiteEWeissNSBone mineral density and breast cancer risk in postmenopausal womenJ Clin Epidemiol200154441742211297892
   PubMed Web of Science ®Google Scholar
• ChlebowskiRTChenZCauleyJAOral bisphosphonate use and breast cancer incidence in postmenopausal womenJ Clin Oncol201028223582359020567009
   PubMed Web of Science ®Google Scholar
• RobbinsJAragakiAKKooperbergCFactors associated with 5-year risk of hip fracture in postmenopausal womenJAMA2007298202389239818042916
   PubMed Web of Science ®Google Scholar
• CardwellCRAbnetCCVealPHughesCMCantwellMMMurrayLJExposure to oral bisphosphonates and risk of cancerInt J Cancer20103046657663
   Google Scholar